Moby summary of ACADIA Pharmaceuticals Inc.'s Q4 2025 earnings call ...
Frost & Sullivan is pleased to announce that Bioiberica has received the 2025 European New Product Innovation Recognition in the innovative collagen solutions industry for its outstanding achievements ...
Continuing with the rare disease theme (Rare Disease Day is Feb 28), Elisabeth Gardiner of Tevard Biosciences explains in a ...
Strategic consultants can drive meaningful innovation by fostering experimentation, leveraging data and integrating diverse ...
Advance your career without a break. JGU’s 12-month online MBA blends flexibility, UGC recognition and elite AACSB ...
Welcome to Lantheus' Fourth Quarter and Full Year 2025 Conference Call. [Operator Instructions] This call is being recorded, and a replay will be available in the Investors section of the company's ...
At this time, I would like to welcome everyone to Harmony Biosciences' Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's ...
Victory Square Technologies Inc. (CSE: VST) (FSE: 6F6) (OTC Pink: VSQTF) (“Victory Square” or the “Company”) provides a ...
HONG KONG, HONG KONG , HONG KONG, January 21, 2026 /EINPresswire.com/ -- As skincare science rapidly evolves toward ...
12d
Isosceles Pharmaceuticals Announces Acceptance of IPI201 for Phase I First-in-Human Clinical Trial
Novel intravenous anti-inflammatory candidate advances to Phase I evaluation to assess safety, tolerability, and ...
Nottingham, England Wednesday, February 18, 2026, 17:00 Hrs [IST] ...
Explore the role of BD&L in R&D decision-making. Understand its impact on funding and market intelligence for scientists.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results